Chemical Component Summary

Name(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
SynonymsTimolol maleate
Identifiers(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
FormulaC13 H24 N4 O3 S
Molecular Weight316.42
TypeNON-POLYMER
Isomeric SMILESCC(C)(C)NC[C@@H](COc1c(nsn1)N2CCOCC2)O
InChIInChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1
InChIKeyBLJRIMJGRPQVNF-JTQLQIEISA-N

Chemical Details

Formal Charge0
Atom Count45
Chiral Atom Count1
Bond Count46
Aromatic Bond Count5

Drug Info: DrugBank

DrugBank IDDB00373 
NameTimolol
Groupsapproved
DescriptionTimolol is a nonselective beta-adrenergic antagonist given in an eye drop solution to reduce intraocular pressure, or pressure in the eyes.[L6724] It is also used in tablet form as a drug to treat hypertension.[L6727] Timolol was first approved by the FDA in 1978.[L6724] This drug is marketed by several manufacturers [L6736] and is an effective agent for the management of conditions such as open-angle glaucoma and hypertension.
Synonyms
  • Timolol
  • Timolol maleate
  • Timololo
  • Timolol anhydrous
  • Timolol hemihydrate
Brand Names
  • Timoptic-XE
  • Dorzolamide HCl and Timolol Maleate
  • Timoptic
  • Timoptic PF
  • Dorzolamide Hydrochloride-Timolol Maleate
Indication Ophthalmic timolol is indicated for the treatment of increased intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The oral form of this drug is used to treat high blood pressure.[L6724,L6727] In certain cases, timolol is used in the prevention of migraine headaches.[A179530,L6742]
Categories
  • Adrenergic Antagonists
  • Adrenergic beta-Antagonists
  • Agents causing hyperkalemia
  • Alcohols
  • Amines
ATC-Code
  • C07AA06
  • S01ED51
  • C07BA06
  • C07DA06
  • S01ED01
CAS number26839-75-8

Drug Targets

NameTarget SequencePharmacological ActionActions
Beta-1 adrenergic receptorMGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESP...unknownantagonist
Beta-2 adrenergic receptorMGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFG...unknownantagonist
LysozymeMNIFEMLRIDERLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAI...unknown
Cytochrome P450 2D6MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...unknownsubstrate
Cytochrome P450 2C19MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDJEYFEY10
PubChem33624
ChEBICHEBI:9599
ChEMBLCHEMBL499
PharosCHEMBL499